Point72 Asset Management, L.P. 13D and 13G filings for Intercept Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:01 pm Sale | 2022-12-31 | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | Point72 Asset Management, L.P. | 392,151 0.900% | -1,968,718 (-83.39%) | Filing |
| 2022-10-11 8:29 pm Purchase | 2022-10-03 | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | Point72 Asset Management, L.P. | 2,360,869 5.700% | 2,360,869 (New Position) | Filing |